The global empty IV bags market size was valued at USD 4.54 billion in 2022. It is estimated to reach USD 9.54 billion by 2031, growing at a CAGR of 8.60% during the forecast period (2023–2031). The increasing government initiatives and the risk of malnutrition promote empty IV bags market growth.
The Empty IV Bags approach is based on customized nutritional intake and personal diet per an individual's health goals. Empty IV Bag plans improve health and minimize risks associated with developing chronic conditions such as obesity, type II diabetes, and cardiovascular diseases. Each individual has unique dietary requirements, as some people opt for customized food for good hair, skin, and nails, while some prefer foods with the least environmental impact. Several consumers adopt ideal diet plans based on their genetic makeup, lifestyle, and environment. Nutrient intake and dietary plans can be adjusted according to the personal health goals of people.
The foundation of Empty IV Bags is the approach that one size does not fit all. Empty IV Bags uses genetic testing to customize the medical treatments of an individual. These dietary recommendations are based on consumers' genetic profiles, metabolism, microbiome composition, and personal wellness goals. Genetic testing kits enable a better understanding of an individual's nutrient intake and nutritional requirements through DNA testing and further understanding of ancestry and family heritage. GeneGene testing may uncover genetic variants that influence dietary components.
Government agencies in several nations are taking measures to reduce the use of phthalates in intravenous bags without jeopardizing patient safety. As part of its initial national phthalate strategy, Denmark, for instance, banned Di-(2-ethylhexyl) phthalate (DEHP), Dibutyl Phthalate (DBP), Dibp Plasticizer (DIBP), and Butyl Benzyl Phthalate (BBP). The Danish Health and Medicines Authority (DHMA) has released a set of guidelines about the decreased use of specific types of phthalates in medical devices.
These initiatives aimed to ensure that the use of classified phthalates in medical devices continued to decline. Favorable reimbursement policies in various nations are anticipated to drive empty IV bags market growth. The CMS in the United States covers a variety of surgical and therapeutic procedures requiring IV bags. Similarly, government agencies in other nations cover a portion of various treatment procedures, which is anticipated to increase the demand for IV bags.
The rising prevalence of malnutrition is another important factor driving the market for empty IV bags. According to the World Health Organization (WHO), millions of people worldwide are suffering from various kinds of malnutrition. Undernourishment is the root cause of over half of all fatalities in children younger than five. It is believed that one out of every six people in the world suffers from malnutrition, which is consistently growing along with the average age of the population.
In addition, malnutrition in the older population is a problem that affects public health and increases mortality and economic loss for individuals and governments. According to the same source, undernourishment is relatively widespread among older persons who are sixty years old or older. The frequency of malnutrition in persons over 60 ranges from 1.3% to 47.8%. It was discovered to be much greater in nations with low and intermediate incomes than those with high incomes.
There is a substantial disparity in price between products made of PVC and those made of alternatives that do not include PVC. Empty IV bags made without the use of PVC are not only more durable than PVC items but also better for the environment. PVC-free empty IV bags cost more than comparable products manufactured in PVC because of these advantages. However, because of the unique relationships between hospitals and suppliers, hospitals can make bulk purchases of empty IV bags free of PVC and pay below-market costs. In addition, to triumph over their rivals, businesses are working hard to provide the greatest discounts possible and devising strategies such as discounts on purchase agreements. The manufacturers' profit margins could be reduced because of this, which would slow the expansion of the market.
The producers of IV bags continually invest money in research and development to improve the bags' appearance and functionality. This allows the manufacturers to improve the functionality of the bags without changing their appearance. This contributes to ensuring that patients receive the highest quality of treatment possible. This area comprises a wide variety of subjects, some of the most important of which include developing novel materials, enhancing medication compatibility, and expanding preventative measures.
Due to technological improvements, manufacturers can now supply customers who demand IV bags without fluids with access to a broader selection of sophisticated and specialized solutions. This is an improvement over the previous situation, in which manufacturers were unable to meet the needs of their customers.
| Study Period | 2019-2031 | CAGR | 8.6% |
| Historical Period | 2019-2021 | Forecast Period | 2023-2031 |
| Base Year | 2022 | Base Year Market Size | USD 4.54 Billion |
| Forecast Year | 2031 | Forecast Year Market Size | USD 9.54 Billion |
| Largest Market | North America | Fastest Growing Market | Europe |
Based on region, the global empty IV bags market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant global empty IV bags market shareholder and is estimated to exhibit a CAGR of 8.4% over the forecast period. North America has the greatest market share and is anticipated to expand significantly throughout the projection period. One of the factors influencing the region's growing use of empty IV bags is the availability of strong distribution channels and the simplicity with which healthcare technologies can be accessed. The adoption of empty IV bags in the region is also anticipated to increase due to the high disease prevalence, supporting reimbursement policies, and well-defined regulatory framework. The FDA has implemented several steps to address the IV solution shortage in North America. According to the guidelines, manufacturers must give the FDA a six-month advance notice of any production halts or drug discontinuations. The FDA is also quickening the review process for new medication applications to facilitate commercializing more IV solution products. This element is anticipated to dominate and drive the market. Additionally, the FDA is working to promote the use of PVC bag alternatives because of the environmental harm caused by PVC bags, which is anticipated to increase the use of non-PVC empty IV bags in the area.
Europe is anticipated to exhibit a CAGR of 8.0% over the forecast period. Europe retained a sizable empty IV bags market share of over 25.68%, thanks to numerous major companies, the rising incidence of cancer, and helpful government measures. For instance, according to the WHO, 1.9 million people die from cancer yearly, and more than 3.7 million new cases are diagnosed. Additionally, it stated that cancer is the area's second leading cause of illness and mortality. Over the forecast period, the non-PVC empty IV bag market is predicted to develop quickly. The market is being stimulated by the European Commission's extensive efforts to regulate risks brought on by the use of PVC and phthalates as raw materials in the manufacture of medical devices.
The Asia Pacific empty IV bag market is predicted to grow quickly over the next years Due to rising healthcare costs, more patient awareness, and a growing demand for innovative and affordable healthcare solutions. In addition, it is anticipated that in the upcoming years, the burden of chronic diseases and the growing older population in the Asia Pacific will increase the demand for empty IV bags. Approximately 1.3 billion people will live in the Asia-Pacific region by 2050; one in four of them will be over 60, according to a report by the United Nations Agency for Sexual and Reproductive Health (UNFPA). According to another survey, the most prevalent illnesses in this area are cancer, diabetes, and cardiovascular disorders. Significant geographical growth prospects for the market are anticipated due to a sizable patient base and the expanding need for technologically sophisticated and affordable healthcare solutions.
Latin America is anticipated to experience significant growth. The expansion of the Latin American market for empty IV bags is mostly driven by rapidly developing economies like Brazil and Mexico. Geographic proximity to the United States, rising medical tourism from North America due to less expensive healthcare facilities, time zone compatibility, rising chronic disease prevalence, and accessibility to modern technologies are some of the key drivers of the market. Additionally, the governments of numerous nations in the region are working to upgrade their healthcare systems. Therefore, the market for empty IV bags in the region is projected to be driven by an increase in people looking for safer healthcare options. The elderly population is more prone to illnesses like cancer and the risk of malnutrition.
The Middle East and Africa market is anticipated to expand significantly during the forecast period. In this region, South Africa, Saudi Arabia, the United Arab Emirates, and Egypt are the nations with the most rapid growth. Growing elderly populations, rising incidence of cardiovascular disorders, and expanding adoption of safer alternatives are all factors that can be linked to the growth of the MEA empty IV bags market. Empty IV bags will be more in demand for treating various illnesses and disorders in the region due to increased government measures to build healthcare infrastructure.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global empty IV bags market is bifurcated into products and materials.
Based on the product, the global empty IV bags market is bifurcated into PVC and non-PVC.
The PVC segment dominates the global market and is projected to exhibit a CAGR of 9.6% over the forecast period. PVC is one of the primary polymers used in creating flexible parenteral packaging films. It is a well-liked material because it offers a variety of beneficial technical characteristics, is relatively inexpensive to produce, and is simple to work with. Additionally, PVC empty IV bags are widely used for packaging rehydration solutions like sodium chloride, lactated Ringer's solution, glucose, sterile water, parenteral nutrition, antibiotics, and analgesics for use in hospitals and veterinary clinics, among other things. Significant industry participants, like RENOLIT SE and Techno Flex, also supply PVC empty IV bags. However, due to several negative consequences of PVC on health, this segment's share is predicted to decrease over the projection period. IV drug administration may be negatively impacted, and patient risk may rise if IV containers made with PVC and DEHP are used. Leaching and adsorption are two elements that contribute to this drawback. DEHP has been linked to various negative side effects, particularly in male neonates, where it may damage the developing baby's reproductive system. DEHP has been labeled a reproductive toxic by the California EPA. As a result, the category is anticipated to lose market share throughout the forecast period.
Based on material, the global empty IV bags market is divided into polypropylene, polyester ether, ethylene-vinyl acetate (EVA), and others.
The ethylene-vinyl acetate (EVA) segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 9.5% over the forecast period. Ethylene Vinyl Acetate (EVA) material is clearer, more transparent, safe, tough, and durable, making it easier to inspect the composition. Furthermore, as more blood banks are worldwide, there is a potential for increased demand and expanding awareness for preserving blood and blood components. EVA is being used more frequently in blood banks to store frozen mixes and blood components. For instance, according to WHO (2020), 106 million blood donations were registered from 13,300 blood centers in 169 countries. Throughout the world, 118.4 million blood donations are made. This will consequently increase demand for PVC-free EVA bags. Additionally, these bags are latex- and DEHP-free. As a result of these reasons, the category is anticipated to experience considerable growth during the forecast period.
